GlassScriptPhysician profile
James R Higgins
NPI 1194727164
$7,437.54
in general payments reported to CMS, 2019-2025
39 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,381 · 2020: $748 · 2021: $1,363 · 2022: $1,503 · 2023: $1,228 · 2024: $958 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,442.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $843.70 | 2019-2024 | Repatha |
| Medtronic, INC. | $645.00 | 2021-2025 | Hawkone, Abre, Protege Rx |
| Novartis Pharmaceuticals Corporation | $596.08 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $584.80 | 2021-2024 | Verquvo |
| Esperion Therapeutics, INC. | $552.31 | 2020-2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $442.21 | 2019-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $290.70 | 2019-2024 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $286.02 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $277.37 | 2019-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $256.55 | 2019-2024 | |
| Boston Scientific Corporation | $253.01 | 2020-2025 | Watchman Flx, Watchman, Watchman Access System |
| W. L. Gore & Associates, INC. | $229.69 | 2019-2025 | Gore Cardioform Septal Occluder |
| Ge Healthcare | $214.31 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $202.48 | 2022-2023 | Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $178.26 | 2021-2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.